ClinicalTrials.Veeva

Menu

Insulin- and Glucose Metabolism in Pulmonary Arterial Hypertension

M

Medical University of Graz

Status

Completed

Conditions

Insulin Resistance

Study type

Observational

Funder types

Other

Identifiers

NCT03584607
29-066 ex 16/17

Details and patient eligibility

About

Insulin resistance is a key mechanism in metabolic disorders, which has also been implicated in the development of pulmonary hypertension. In this pilot study, the investigators´ goal is to directly determine insulin sensitivity in idiopathic pulmonary arterial hypertension patients and to compare the results with data from healthy controls.

Enrollment

10 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • signed informed consent form
  • patients with idiopathic or hereditary pulmonary hypertension / healthy controls

Exclusion criteria

  • premenopausal women
  • other relevant lung disease
  • relevant left heart disease
  • untreated systemic hypertension
  • Diabetes mellitus
  • pulmonary hypertension other than idiopathic or hereditary form

Trial design

10 participants in 2 patient groups

Idiopathic Pulmonary Arterial Hypertension patients
Description:
Blood sampling Insulin resistance-measurement
Healthy controls
Description:
Blood sampling Insulin resistance-measurement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems